February 15, 2017
Merck announces the end of another anti-amyloid drug trial, calling in to question the amyloid hypothesis and the fate of other anti-amyloid drugs.
November 25, 2016
Eli Lilly announced that its Alzheimer's drug solanezumab failed in its last phase 3 clinical trial. Howard Fillit, MD, discusses what this means, and where we go from here.
September 2, 2016
A treatment has reduced beta-amyloid plaques in the brains of patients with Alzheimer’s disease.